{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Laniquidar",
  "nciThesaurus": {
    "casRegistry": "197509-46-9",
    "chebiId": "",
    "chemicalFormula": "C37H36N4O3",
    "definition": "A stereoisomer of verapamil and third-generation P-glycoprotein inhibitor. Laniquidar inhibits the drug efflux pump P-glycoprotein, resulting in higher concentrations of antineoplastic agents in tumor cells that are multi-drug resistant due to the overexpression of P-glycoprotein.",
    "fdaUniiCode": "K3FRN4DDOY",
    "identifier": "C28698",
    "preferredName": "Laniquidar",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1744"
    ],
    "synonyms": [
      "LANIQUIDAR",
      "Laniquidar",
      "R101933"
    ]
  }
}